Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Digia and Avalon join forces

Digia continues purposefully implementing its strategy and acquires Avalon, a company focused on digital marketing and customer experience development. Avalon’s understanding of the development of a data-based real-time customer experience and the management of that development, combined with Digia’s well-known business and design consulting expertise, strengthen Digia’s role in the market as a pioneering supplier of broader data- and analytics-based digital service packages. Together, the two companies are able to offer customers significant added value when it comes to digital services and

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital20 September 2022 at 9.15 EET Nordea has today cancelled 21,299,414 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,714,243,282. The total number of votes attached to the shares is 3,714,243,282. The cancellation of the shares was registered with the Finnish Trade Register on 20 September 2022. The company holds 4,193,

Evusheld approved in EU for COVID-19 treatment

20 September 2022 07:00 GMT Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19 Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial   AstraZeneca's Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination, has been approved in the European Union (EU) for the treatment of adults and adolescents (aged 12 years and older weighing at least 40 kg) with COVID‑19 who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID‑19.

TIE Kinetix Signs Contract with Clopay Building Products for a 100% Cloud-Based Supply Chain

TIE Kinetix  announced today a new 5-year, $500,000 contract with Clopay Building Products, a leading manufacturer of residential and commercial garage doors. With this upgrade towards TIE Kinetix's FLOW Partner Automation platform, Clopay’s supply chain solution will move 100% to the cloud.The contract enables Clopay to move 100% to the cloud with a managed service agreement with TIE Kinetix, further optimizing their document exchange processes. All business partners of Clopay will continue to be able to exchange documents such as purchase orders, order

Peab builds tenant-owner apartments in Malmö

Peab has been commissioned to build 78 apartments in Limhamn in Malmö. The customer is HSB Projekt i Malmö HB and the contract is worth SEK 194 million.The project consists of four separate buildings with four to seven floors where the top floor is recessed in all the buildings. They are connected by a shared garage and basement with a tech room and storage.  “We’re proud to contribute with our expertise and by building more housing for Malmö residents. This is a good example of our locally produced community building,” says Peter Lindstedt, Region Manager Peab. The project is a

Inhalation Sciences to present findings of PreciseInhale clinical study at DDL 2022

(Stockholm 20 September 2022) ISAB’s conference paper on its study validating PreciseInhale[®] for clinical use has been accepted by the Drug Delivery to the Lungs (DDL) conference 2022 - one of the inhalation markets’ most influential events. The study demonstrates that PreciseInhale[®] outperformed standard commercial inhalers and improved ‘regional targeting’ of aerosols to specific areas of the lungs. The data will be presented as a Poster at the event.DDL 2022 (7- 9 December, Edinburgh, Scotland) will be a particularly important event as it will be the first to be held entirely onsite

Top-Line Data on Bexmarilimab Dose Variation

Faron Pharmaceuticals Ltd (“Faron or Company”)   Faron Pharmaceuticals Announces Top-Line Data on Bexmarilimab Dose Variation from MATINS Advanced Solid Tumor Patients   · Bexmarilimab was well tolerated in patients receiving higher dose levels or frequency of administration · Treatment induced significant systemic interferon (IFN) gamma increase - again showing the capacity of bexmarilimab to activate immune response in cancer patients, especially in patients with immunologically “cold” tumors · Higher baseline Clever-1 levels in the tumors was associated with

Ericsson publishes restated segment financials

· Ericsson has published restated segment financials for 2020 full year, 2021 by quarter and 2022 Q1 and Q2 following the changed reporting structure as of Q3 2022 · Conference call with CFO Carl Mellander for financial analysts, investors and journalists at 3:00 PM CEST, September 20, 2022As announced in May 2022, Ericsson (NASDAQ: ERIC) will start to report financials according to its new segment structure as of the third quarter 2022. To facilitate year-on-year comparisons, Ericsson today publishes the restated segment financials for 2020 full year; 2021 by quarter and 2022 Q1 and Q2.

Zalaris to deliver outsourced payroll services based on PeopleHub to global pharmaceutical company

Zalaris, the provider of payroll and HR solutions that simplify work life and support creating sustainable businesses, today announced the signing of an agreement with a leading global pharmaceutical company for the provision of outsourced payroll services in Germany and Switzerland.Zalaris has signed a five-year agreement to deliver a new outsourced payroll solution and outsourcing services to serve the global pharma company’s 6,000+ employees in Germany and Switzerland. The solution that will be implemented over the next 18 months with first go-live in July 2023 is based on Zalaris

Composition of Nordea Bank Abp’s Shareholders’ Nomination Board

Nordea Bank AbpStock exchange release – Other information disclosed according to the rules of the Exchange20 September 2022 at 9.00 EET Nordea’s Shareholders’ Nomination Board has been appointed. The Nomination Board consists of the Chair of the Board of Directors and the four largest shareholders, who on 31 August represent the largest number of voting rights and wish to participate in the work of the Nomination Board. The members of the Nomination Board are: · Niko Pakalén, Partner, Cevian Capital · Lars Ingemann Nielsen, Executive Vice President and CFO, Nordea-fonden

BioStock: Positive results from Respiratorius’s PK study

Lund-based Respiratorius is in full swing with analysing the results from the PK study with VAL001 that took place during the summer. Now, a first reading of the results are out, and the company has been granted a patent from the Japanese Patent Office. BioStock contacted the company’s CEO Johan Drott to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2022/09/positive-results-from-respiratoriuss-pk-study/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Kongsberg Automotive wins contract worth EUR 32.6 million in estimated lifetime revenue

Kongsberg Automotive (KA)’s Powertrain and Chassis (P&C) business segment has secured a contract worth EUR 32.6 million in estimated lifetime revenue corresponding to annual revenue of EUR 6.5 million. P&C was awarded this contract by a global original equipment manufacturer (OEM), for a family of stalk devices, which uses the right-hand stalk attached to the steering column as a shift-by-wire shifter for Automatic Manual Transmissions (AMT) as well as the addition of variants for Manual Transmission (MT) applications.  This product is KA’s first for the new generation of ASIL B,

New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesia

Press release – Oslo, Norway, September 20th, 2022: Photocure ASA, The Bladder Cancer Company, announces the publication of first results from the Laser III clinical study in the medical journal, European Urology. The study is part of a systematic program aimed at verifying the safe treatment of bladder tumors in the outpatient setting. Laser III results demonstrate the non-inferiority of outpatient laser-mediated destruction of bladder tumors in conjunction with blue light cystoscopy (BLC[®]) and Hexvix[®] versus inpatient BLC TURBT* under general anesthesia. Photocure has supported this

Share buy-backs in Telia Company during week 37 2022

Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased own shares (ISIN: SE0000667925) as specified in the table below. The share buy-backs form part of the SEK 5.4 billion share buy-back program that Telia Company announced on June 1, 2022 . The share buy-back program is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”)

Investment Outlook: Finding ways out of a barren landscape

The economic situation has deteriorated further since the summer. We are heading into a clear slowdown, perhaps best described as a mild recession. We expect genuine weakness in 2023 as a whole, but we believe that 2024 will show a clear improvement in economic growth. Falling growth and rising inflation have had a severe impact on stock and fixed income markets. But depressed risk appetite, more palatable valuation levels and a light on the economic horizon will help us to achieve a balanced picture of the appropriate risk level in our portfolios, despite potential hazards. “We believe

Bonava sells a total of 313 rental apartments in Finland

Bonava is selling 313 sustainable rental apartments in the Helsinki region, Finland, to the investor Taaleri. The transaction includes three rental housing projects and amounts to EUR 85 million. The first housing units are expected to be completed and handed over to the customer in the fourth quarter of 2023. The projects have a strong sustainability profile and will be constructed to comply with the requirements for energy class A.–  This important transaction strengthens our excellent partnership with Taaleri. We appreciate that energy efficiency and climate change are on Taaleri’s

Nordea Bank Abp: Repurchase of own shares on 19.09.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares19.09.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 19.09.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XHEL 843,802 9.08 7,658,262.57CEUX 461,744 9.07 4,189,934.21TQEX 59,042 9.07 535,743.23XSTO 391,820 9.07 3,

Tecnotree Oyj - Managers' Transactions

Tecnotree Corporation Stock Exchange Release 19 September 2022 at 19:00 EETPerson subject to the notification requirementName: Sanjay KetkarPosition: Other senior manager Issuer: Tecnotree OyjLEI: 743700MRPVYI7ASHCX38Notification type: INITIAL NOTIFICATIONReference number: 19715/4/4____________________________________________ Transaction date: 2022-09-16Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009010227Nature of the transaction: DISPOSAL Transaction details(1): Volume: 2762 Unit price: 0.5085 EUR(2): Volume: 986 Unit price: 0.507 EUR(

Mandatory notification of trade

On September 19, 2022, Systemintegration ApS, controlled by Ib Kunøe acquired 86,496 shares in Atea ASA at a price of NOK 100,90. Ib Kunøe is primary insider and the Chairman of the Board of Atea ASA. Following the transaction, Ib Kunøe and close associates controls 31,945,145 shares in Atea ASA, representing 28.4% of the share capital. For further information, please contact:Robert Giori, CFO Atea ASA, mobile +47 934 09 188Ole Johan Fjellestad, Group Chief Accountant, mobile +47 992 74 829

#22-326 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

CEO Anders Fogelberg reduces shareholding

On September 19, 2022, FlexQube's CEO Anders Fogelberg sold 310,000 shares in FlexQube AB (publ) via his company Birdmountain Invest AB. Anders Fogelberg's holdings then amount to a total of 946,483 shares, which makes him FlexQube's fourth largest owner. All buyers of the shares are existing shareholders in FlexQube. Håkan Roos, through Roosgruppen, increases his existing shareholding by 200,000 shares and subsequently owns 1,432,000 shares. Brofund Equity buys 100,000 shares and thus increases to 185,000 shares in the company, and Mikael Bluhme, who is a board member in FlexQube,

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.09.2022

Fiskars Corporation   Stock Exchange Release 19.09.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.09.2022   Date 19.09.2022  Exchange transaction Buy  Share class FSKRS  Amount  9,500  Average price/share 15.6751 EURHighest price/share 15.7600 EURLowest price/share 15.6400 EURTotal price 148,913.45 EUR        The shares held by Fiskars Corporation on 19.09.2022   FSKRS 1,119,653       On

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 19.09.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    19.09.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 19.09.2022   Date 19.09.2022  Exchange transaction Buy  Share class ALEX  Amount 540  Average price/share 6.5636   EURHighest price/share 6.5800   EURLowest price/share 6.5600   EURTotal price 3,544.34 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 19.09.

There are no items matching the current filter
There are no more items matching the current filter
Back to top